Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 10
1999 10
2000 17
2001 12
2002 13
2003 25
2004 23
2005 20
2006 24
2007 28
2008 19
2009 21
2010 19
2011 26
2012 30
2013 43
2014 30
2015 40
2016 32
2017 37
2018 34
2019 31
2020 36
2021 32
2022 31
2023 31
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

602 results

Results by year

Filters applied: . Clear all
Page 1
Potassium channels and epilepsy.
Gao K, Lin Z, Wen S, Jiang Y. Gao K, et al. Acta Neurol Scand. 2022 Dec;146(6):699-707. doi: 10.1111/ane.13695. Epub 2022 Oct 12. Acta Neurol Scand. 2022. PMID: 36225112 Review.
Hyperexcitable arousal circuits drive sleep instability during aging.
Li SB, Damonte VM, Chen C, Wang GX, Kebschull JM, Yamaguchi H, Bian WJ, Purmann C, Pattni R, Urban AE, Mourrain P, Kauer JA, Scherrer G, de Lecea L. Li SB, et al. Science. 2022 Feb 25;375(6583):eabh3021. doi: 10.1126/science.abh3021. Epub 2022 Feb 25. Science. 2022. PMID: 35201886 Free PMC article.
Ligand activation mechanisms of human KCNQ2 channel.
Ma D, Zheng Y, Li X, Zhou X, Yang Z, Zhang Y, Wang L, Zhang W, Fang J, Zhao G, Hou P, Nan F, Yang W, Su N, Gao Z, Guo J. Ma D, et al. Nat Commun. 2023 Oct 19;14(1):6632. doi: 10.1038/s41467-023-42416-x. Nat Commun. 2023. PMID: 37857637 Free PMC article.
Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2.
Lopez JP, Lücken MD, Brivio E, Karamihalev S, Kos A, De Donno C, Benjamin A, Yang H, Dick ALW, Stoffel R, Flachskamm C, Ressle A, Roeh S, Huettl RE, Parl A, Eggert C, Novak B, Yan Y, Yeoh K, Holzapfel M, Hauger B, Harbich D, Schmid B, Di Giaimo R, Turck CW, Schmidt MV, Deussing JM, Eder M, Dine J, Theis FJ, Chen A. Lopez JP, et al. Neuron. 2022 Jul 20;110(14):2283-2298.e9. doi: 10.1016/j.neuron.2022.05.001. Epub 2022 May 31. Neuron. 2022. PMID: 35649415 Free article.
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial.
Costi S, Morris LS, Kirkwood KA, Hoch M, Corniquel M, Vo-Le B, Iqbal T, Chadha N, Pizzagalli DA, Whitton A, Bevilacqua L, Jha MK, Ursu S, Swann AC, Collins KA, Salas R, Bagiella E, Parides MK, Stern ER, Iosifescu DV, Han MH, Mathew SJ, Murrough JW. Costi S, et al. Am J Psychiatry. 2021 May 1;178(5):437-446. doi: 10.1176/appi.ajp.2020.20050653. Epub 2021 Mar 3. Am J Psychiatry. 2021. PMID: 33653118 Free PMC article. Clinical Trial.
Triclosan is a KCNQ3 potassium channel activator.
De la Rosa V, Guzmán-Hernández ML, Carrillo E. De la Rosa V, et al. Pflugers Arch. 2022 Jul;474(7):721-732. doi: 10.1007/s00424-022-02692-w. Epub 2022 Apr 22. Pflugers Arch. 2022. PMID: 35459955
Precision Therapy in KCNQ2-Related Epilepsy.
Borggraefe I, Wagner M. Borggraefe I, et al. Neuropediatrics. 2023 Oct;54(5):295-296. doi: 10.1055/s-0043-1772667. Epub 2023 Sep 18. Neuropediatrics. 2023. PMID: 37722392 No abstract available.
602 results